Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

7-ethyl-10-hydroxycamptothecin-derived prodrug-encapsulated polymer nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

1

poly(ethylene glycol)-block-poly(D,L-lactic acid)

PEG5K-PLA16K
Type Polymer
Formula
Role carriers
2

1,4,5,8,9-pentamethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl 4-{[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-7-yl]oxy}pent-4-enoate

Type Single Compound
Formula C44H52N2O11
Role loaded material

Properties

General physical and chemical properties

Property Value Source
drug release

More information available to subscribers only.

Or, view sample content

Applications

Characterization

Method Source
transmission electron microscopy

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
HCT-116 colorectal xenograft mouse

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • poly(ethylene glycol)-block-poly(D,L-lactic acid)
  • 1,4,5,8,9-pentamethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl 4-{[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-7-yl]oxy}pent-4-enoate
  1. fGkXEwiaMNbO
  2. FAn2M
Product

7-ethyl-10-hydroxycamptothecin-derived prodrug-encapsulated polymer nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial